...
首页> 外文期刊>Journal of Medicinal Chemistry >6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to beta-Lactam Antibiotics
【24h】

6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to beta-Lactam Antibiotics

机译:基于6-卤代吡啶甲基青霉素的砜有效地灭活假单胞菌铜绿假单胞菌至β-内酰胺抗生素的耐受性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pseudomonas aeruginosa, a major cause of nosocomial infections, is considered a paradigm of antimicrobial resistance, largely due to hyperproduction of chromosomal cephalosporinase AmpC. Here, we explore the ability of 6-pyridylmethylidene penicillin-based sulfones 1-3 to inactivate the AmpC beta-lactamase and thus rescue the activity of the antipseudomonal ceftazidime. These compounds increased the susceptibility to ceftazidime in a collection of clinical isolates and PAO1 mutant strains with different ampC expression levels and also improved the inhibition kinetics relative to avibactam, displaying a slow deacylation rate and involving the formation of an indolizine adduct. Bromide 2 was the inhibitor with the lowest K-I (15.6 nM) and the highest inhibitory efficiency (k(inact)/K-I). Computational studies using diverse AmpC enzymes revealed that the aromatic moiety in 1-3 targets a tunnel-like site adjacent to the catalytic serine and induces the folding of the H10 helix, indicating the potential value of this not-always-evident pocket in drug design.
机译:铜绿假单胞菌是医院感染的主要原因,被认为是耐药性的典范,主要是由于染色体头孢菌素酶AmpC的大量产生。在这里,我们探索了6-吡啶亚甲基青霉素基砜1-3灭活AmpCβ-内酰胺酶从而拯救抗假性头孢他啶活性的能力。这些化合物增加了一系列临床分离株和具有不同ampC表达水平的PAO1突变株对头孢他啶的敏感性,还改善了与阿维巴坦相关的抑制动力学,表现出缓慢的脱酰基速率,并涉及吲哚嗪加合物的形成。溴化物2是K-I最低(15.6nm)和抑制效率最高(K(inact)/K-I)的抑制剂。使用多种AmpC酶进行的计算研究表明,1-3中的芳香部分靶向催化丝氨酸附近的隧道状位点,并诱导H10螺旋的折叠,这表明这种并不总是明显的口袋在药物设计中的潜在价值。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2021年第9期|共19页
  • 作者单位

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Univ Santiago de Compostela Ctr Singular Invest Quim Biol &

    Mat Mol CiQUS Dept Quim Organ Santiago De Compostela 15782 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Univ Santiago de Compostela Ctr Singular Invest Quim Biol &

    Mat Mol CiQUS Dept Quim Organ Santiago De Compostela 15782 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Univ Santiago de Compostela Ctr Singular Invest Quim Biol &

    Mat Mol CiQUS Dept Quim Organ Santiago De Compostela 15782 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Hosp Univ Son Espases Inst Invest Sanitaria Illes Balears IdiSBA Serv Microbiol Palma De Mallorca 07120 Spain;

    Hosp Univ Son Espases Inst Invest Sanitaria Illes Balears IdiSBA Serv Microbiol Palma De Mallorca 07120 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

    Univ Santiago de Compostela Ctr Singular Invest Quim Biol &

    Mat Mol CiQUS Dept Quim Organ Santiago De Compostela 15782 Spain;

    Complejo Hosp Univ Coruna CHUAC Inst Invest Biomed Coruna CICA INIBIC Serv Microbiol La Coruna 15006 Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号